(Q45259661)

English

PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways

scientific article published in April 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways (English)

1 reference

Europe PubMed Central

11 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

D C Linch

1 reference

Europe PubMed Central

11 December 2017

2

object named as

R E Gale

1 reference

Europe PubMed Central

11 December 2017

author name string

V L Grandage

1

1 reference

Europe PubMed Central

11 December 2017

A Khwaja

4

1 reference

Europe PubMed Central

11 December 2017

publication date

1 April 2005

1 reference

Europe PubMed Central

11 December 2017

1 reference

Europe PubMed Central

11 December 2017

19

1 reference

Europe PubMed Central

11 December 2017

586-594

1 reference

Europe PubMed Central

11 December 2017

4

1 reference

Europe PubMed Central

11 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403653

0 references

Class I phosphoinositide 3-kinases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of acute myeloid leukemia cells requires PI3 kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and characterization of a conditionally active version of the serine/threonine kinase Akt.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of p53 in chemosensitivity and radiosensitivity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403653

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403653

1 reference

Europe PubMed Central

11 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45259661&oldid=2071848738"